Cyanta Drug Development Services is solely dedicated to assisting pharmaceutical, biotechnology and medical device companies
achieve their regulatory registration goals through extensive analytical testing and support services. The spin of Chemir
Analytical Services' pharmaceutical group, we are outfitting a new facility with state-of the-art instrumentation and systems
to continue to meet expectations of compliance and timely service. Our background of solving challenging analytical problems
and providing drug development services has enabled us to become a premiere drug development partner.
We help large to virtual pharmaceutical and medical device companies.
Products and Services
We specialize in non-routine analysis for drug substances and excipients, oral dosages (tablets, capsules), topical dosages
(creams, ointments, lotions), liquid dosages (injectables, suspensions), inhalation dosages (MDI, DPI, Nasal), and medical
devices (implantables, flexible tubing, containers and protective devices).
Technical Services: Cyanta has numerous capabilities to support your drug and medical device development efforts. These services
include method development, method validation, stability studies under ICH conditions, degradation studies, dissolution testing,
release testing, extractables/leachables programs for medical devices, custom synthesis, reference standard characterization,
formulation support, consulting services and variety of other services designed to meet your regulatory goals in a timely
Centrally located in suburban St. Louis, MO, our facility is FDA registered, cGMP/GLP compliant and DEA licensed. Instrumentation
includes LC/MSn, HPLC, GPC, ICP, DSC, FT-IR, SEM/EDXA, GC/MS, NMR, physical-testing equipment for medical devices and more.
We are scheduled to move into a newly renovated, state- of-the-art 25,000-sq. ft. facility in early 2007, adjacent to our
CYANTA DRUG DEVELOPMENT SERVICES
2672 Metro Blvd
Maryland Heights, MO